Nurse Practitioner, Family · Baton Rouge, LA
NPI
1639503550
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
5131 Odonovan Dr Ste 100
Baton Rouge, LA, 70808
Phone (225) 767-4893
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,987
87 services
Medicare patients, 2024
35
Average age 63
Drug cost, 2024
$1.0M
2,070 prescriptions
Company payments, 2025
$1,025
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natasha F Lewis was code 99496 (chronic, principal, and transitional care management), 15 times for 11 patients. In total Natasha F Lewis billed 87 services in 7 codes, and Medicare paid $8,987.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99496 Chronic, Principal, and Transitional Care Management | Office | 15 | 11 | $163.05 | $2,446 |
| 90961 ESRD Related Services (not dialysis) | Office | 14 | 12 | $196.55 | $2,752 |
By year: 2022 $11K for 88 services; 2023 $7,997 for 67 services; 2024 $8,987 for 87 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natasha F Lewis prescribed most often to Medicare patients was Velphoro (Sucroferric Oxyhydroxide), with 172 prescriptions and refills. In total Natasha F Lewis wrote 2,070 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Velphoro Sucroferric Oxyhydroxide | 172 | 182 | 46 | $438K |
| Amlodipine Besylate Generic | 160 | 320 | 57 | $608 |
| Losartan Potassium Generic | 146 | 272 | 41 | $897 |
| Sevelamer Carbonate Generic | 121 | 145 | 46 | $14K |
| Auryxia Ferric Citrate | 118 | 152 | 38 | $245K |
| Furosemide Generic | 116 | 207 | 41 | $561 |
| Hydralazine Hcl Generic | 104 | 156 | 34 | $1,363 |
| Doxazosin Mesylate Generic | 63 | 131 | 26 | $759 |
| Carvedilol Generic | 62 | 106 | 27 | $348 |
| Lisinopril Generic | 51 | 93 | 15 | $213 |
| Jardiance Empagliflozin | 47 | 51 | 12 | $30K |
| Lokelma Sodium Zirconium Cyclosilicate | 41 | 48 | 14 | $34K |
| Gabapentin Generic | 40 | 54 | 15 | $219 |
| Veltassa Patiromer Calcium Sorbitex | 38 | 44 | 15 | $34K |
| Potassium Chloride Generic | 37 | 63 | 13 | $473 |
Brand drugs: - claims; generic drugs: 1,486 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natasha F Lewis $1,025 ($1,025 in general payments such as food, travel and fees) from 20 companies. The largest payer was Fresenius USA Marketing, Inc. with $192.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 9 | $192 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $104 |
| Mallinckrodt Hospital Products Inc. | 5 | $95.47 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $85.67 |
| NxStage Medical, Inc. | 1 | $75.76 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $65.85 |
| Calliditas Therapeutics US Inc. | 2 | $60.4 |
| OPKO Pharmaceuticals, LLC | 3 | $49.99 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $37.62 |
| Akebia Therapeutics Inc AKBA | 1 | $37.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.